previous compound ID: 1522 next compound
InChIKey: NUZWLKWWNNJHPT-UHFFFAOYSA-N
SMILES: C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "E Matthes" "R Robert" "J Liao" "GW Carlile" "JW Hanrahan" "B Kus" "D Rotin" "J Goepp" "DY Thomas"

chemical graph of compound 1522





CID is 2202
synonyms found at PubChem are:
anthralin, Dithranol, 1143-38-0, 1,8-Dihydroxyanthrone, 1,8-Dihydroxy-9-anthrone, Chrysodermol, Cigthranol, Cignolin, 1,8-Dihydroxyanthracen-9(10H)-one, Batridol, Psoriacid-Stift, 9(10H)-Anthracenone, 1,8-dihydroxy-, Anthra-Derm, Drithoscalp, DrithoCreme, Anthrone, 1,8-dihydroxy-, NSC 43970, 1,8-dihydroxy-10H-anthracen-9-one, 1,8-DIHYDROXY-9(10H)-ANTHRACENONE, Anthraline, NSC 629313, UNII-U8CJK0JH5M, Dithranolum [INN-Latin], Anthralin [USP], CCRIS 628, CHEBI:37510, 1,8 Dihydroxyanthrone, EINECS 214-538-0, U8CJK0JH5M, BRN 2054360, CHEMBL46469, NUZWLKWWNNJHPT-UHFFFAOYSA-N, Anthralin (USP), Dithranol (INN), Dithranol [INN], NSC629313, NCGC00091330-01, DSSTox_CID_4538, 1,8-Dihydroxy-9(10H)-anthracenone;Anthralin, DSSTox_RID_77448, DSSTox_GSID_24538, W-108602, Dithranolum, Zithranol-RR, CAS-1143-38-0, SR-05000002011, Psodadrate, Prestwick_528, Anthralin, Dithranol, Dithranol ,(S), Anthralin (Dithranol), Anthrone,8-dihydroxy-, Spectrum_000056, ANTHRADERM (TN), Spectrum2_000111, Spectrum3_000304, Spectrum4_000151, Spectrum5_000820, Epitope ID:114081, 1,8-dihydroxy-9-anthrane, AC1L1D5I, cid_2202, SCHEMBL3197, BSPBio_001868, KBioGR_000622, KBioSS_000436, MLS001332632, MLS002415712, DivK1c_000021, SPECTRUM1500127, SPBio_000122, AC1Q794G, ZINC1322, Dithranol, >=90% (HPLC), DTXSID7024538, CTK8A0163, HMS500B03, KBio1_000021, KBio2_000436, KBio2_003004, KBio2_005572, KBio3_001368, NUZWLKWWNNJHPT-UHFFFAOYSA-, MolPort-001-792-502, NINDS_000021, HMS1920E07, HMS2091K07, HMS2271B09, HMS3715H19, Pharmakon1600-01500127, HY-B0738, NSC43970, 9(10H)-Anthracenone,8-dihydroxy-, Tox21_111115, Tox21_201851, Tox21_300290, BDBM50041802, CCG-38920, LS-570, MFCD00053409, NSC-43970, NSC755873, 1,8-dihydroxy-9-(10H)anthracenone, AKOS015914122, Tox21_111115_1, API0002431, CS-2980, DB11157, KS-5183, MCULE-8492759735, NSC-629313, NSC-755873, 1,8-dihydroxy-10-hydroanthracen-9-one, IDI1_000021, 1,8-Dihydroxy-9(10H)-anthracenone #, NCGC00091330-02, NCGC00091330-03, NCGC00091330-04, NCGC00091330-05, NCGC00091330-07, NCGC00253941-01, NCGC00259400-01, AC-14842, AJ-08003, AK481321, AN-20615, CJ-00043, NCI60_004019, SC-19051, SBI-0051286.P003, AB0105711, FT-0625372, ST50825759, C06831, D00233, K-1044, 9(10H)-Anthracenone, 1,8-dihydroxy- (9CI), AB00051916_07, SR-05000002011-1, SR-05000002011-2, I14-44798, Dithranol, European Pharmacopoeia (EP) Reference Standard, Anthralin, United States Pharmacopeia (USP) Reference Standard, Anthralin (Dithranol), Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2